Analysis in progress
Initialising…
0%
complete
This report is still being assembled — sections appear as each stage finishes. It isn't final yet.
POLE
Final classification
In progress — classification not generated yet.
POLE c.1360-6C>T · p.?
POLE

In progress — classification not generated yet.

Gene
POLE
Transcript
NM_006231.4
HGVS · transcript:coding
NM_006231.4:c.1360-6C>T
Consequence
N/A
exon NC_000012.11
GRCh38
chr12:132673283 G>A
GRCh37
chr12:133249869 G>A
Basis In progress — classification not generated yet.
In progress — classification not generated yet.
Classification rationale
In progress — classification not generated yet.

No rationale recorded.

Gene diagram · NM_006231.4 · variants mapped to exon structure
POLE NM_006231.4
Fetching transcript structure from UCSC…
Applied criteria · 0 applied · 28 assessed
Applied · 0

No criteria were applied for this variant.

Assessed · not applied
Pathogenic
PVS1
PS1
PS2
PS3
PS4
PM1
PM2
PM3
PM4
PM5
PM6
PP1
PP2
PP3
PP4
PP5
Benign
BA1
BS1
BS2
BS3
BS4
BP1
BP2
BP3
BP4
BP5
BP6
BP7
Research & evidence
Population frequency
gnomAD v4.1 screenshot
gnomAD v4.1
gnomAD v2.1 screenshot
gnomAD v2.1
v4.1
This variant is present in gnomAD v4.1 (AF= 0.00023874; MAF= 0.02387%, 376/1574938 alleles, homozygotes = 3) and has highest observed frequency in the African/African American population (AF= 0.00353128; MAF= 0.35313%, 262/74194 alleles, homozygotes = 2); grpmax FAF= 0.00317984.
v2.1
This variant is present in gnomAD v2.1 (AF= 0.000357224; MAF= 0.03572%, 101/282736 alleles, homozygotes = 0) and has highest observed frequency in the African/African American population (AF= 0.00324389; MAF= 0.32439%, 81/24970 alleles, homozygotes = 0); grpmax FAF= 0.00250493.
🇨🇦 CA
Not available in gnomAD-Canada v1.0.
Allele frequency by ancestry
three datasets · side by side
gnomAD v4.1
0.024% · 376 / 1,574,938
3 hom · FAF 0.32%
African/African American
262 / 74,194
0.35%
2 hom
Middle Eastern
14 / 5,992
0.23%
Remaining individuals
40 / 61,148
0.065%
Admixed American
28 / 59,988
0.047%
South Asian
13 / 90,316
0.014%
1 hom
European (non-Finnish)
19 / 1,144,342
0.0017%
+ 4 not observed (European (Finnish), Amish, East Asian, Ashkenazi Jewish)
gnomAD v2.1
0.036% · 101 / 282,736
0 hom · FAF 0.25%
African/African American
81 / 24,970
0.32%
Remaining individuals
4 / 7,222
0.055%
Admixed American
11 / 35,434
0.031%
South Asian
2 / 30,614
0.0065%
European (non-Finnish)
3 / 129,086
0.0023%
+ 3 not observed (Ashkenazi Jewish, East Asian, European (Finnish))
gnomAD Canada 🇨🇦
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
ClinVar screenshot
ClinVar
In progress — evidence not uploaded yet.
SpliceAI screenshot
In silico
In progress — evidence not uploaded yet.
Functional
In progress — evidence not uploaded yet.
OncoKB ↗
COSMIC screenshot
COSMIC
Somatic evidence
COSMIC
In progress — evidence not uploaded yet.
Hotspots
This variant does not lie in a statistically significant cancer hotspot.
COSMIC ↗
Sources & reference links
7Sources
ClinVar
gnomAD v2.1
gnomAD v4.1
gnomAD-Canada
SpliceAI
OncoKB
COSMIC
Triaged references · 6 PMIDs not cited in assessment
25394175 ↗ A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. CLINVAR
25741868 ↗ Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. CLINVAR
26389258 ↗ PMID 26389258 CLINVAR
26389505 ↗ Genetics of Colorectal Cancer (PDQ®): Health Professional Version. CLINVAR
26467025 ↗ A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders. CLINVAR
28492532 ↗ Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. CLINVAR